Meridian Bioscience, Inc. (VIVO) Reports In-Line Q2 EPS
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q2 EPS of $0.24 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
